Verano Holdings (VRNO) Other Non-Current Assets (2021 - 2026)
Verano Holdings (VRNO) reported Other Non-Current Assets of $10.0 million for Q1 2026, down 24.69% year-over-year from $13.3 million in Q1 2025, and down 5.21% quarter-over-quarter from $10.6 million in Q4 2025.
Verano Holdings (VRNO) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Other Non-Current Assets data on file, last reported at $10.0 million in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $10.0 million, down 24.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.0 million (down 24.69% YoY), and the FY2025 annual result was $10.6 million, down 20.76% from the prior year.
- Other Non-Current Assets retreated to $10.0 million in Q1 2026 per VRNO's latest filing, from $10.6 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $14.0 million in Q2 2025 and troughed at $2.6 million in Q2 2022.
- A 5-year average of $11.2 million and a median of $12.9 million in 2022 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2023 and 2026: Other Non-Current Assets surged 422.31% in 2023, then retreated 24.69% in 2026.
- A 5-year view of Other Non-Current Assets shows it stood at $12.8 million in 2022, then slipped by 3.27% to $12.3 million in 2023, then climbed by 7.97% to $13.3 million in 2024, then decreased by 20.76% to $10.6 million in 2025, then retreated by 5.21% to $10.0 million in 2026.
- Business Quant data shows VRNO's Other Non-Current Assets at $10.0 million in Q1 2026, $10.6 million in Q4 2025, and $13.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Verano Holdings | - | - | 98.98 Mn | 10.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.02 Mn |
| Dec 31, 2025 | 10.57 Mn |
| Sep 30, 2025 | 13.14 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 13.30 Mn |
| Dec 31, 2024 | 13.33 Mn |
| Sep 30, 2024 | 13.07 Mn |
| Jun 30, 2024 | 11.28 Mn |
| Mar 31, 2024 | 10.50 Mn |
| Dec 31, 2023 | 12.35 Mn |
| Sep 30, 2023 | 13.82 Mn |
| Jun 30, 2023 | 13.31 Mn |
| Mar 31, 2023 | 13.33 Mn |
| Dec 31, 2022 | 12.77 Mn |
| Sep 30, 2022 | 2.65 Mn |
| Jun 30, 2022 | 2.58 Mn |
| Dec 31, 2021 | 2.50 Mn |